About 1 result found for searched term "1858206-58-2" (0.117 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M28956 | Edralbrutinib | BTK |
| TG-1701 | ||
| Edralbrutinib (TG-1701) is a potent, novel, orally active, irreversible BTK inhibitor that selectively inhibits the activation, proliferation, and survival of B cells, and can act on other immune cells, such as macrophages, to influence the autoimmune inflammatory process mediated by B cells and other immune cells, and can be used in the study of optic neuromyelitis optica spectrum disorders (NMOSD). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
